Physiological & Pharmacokinetic Considerations for Optimizing Oligonucleotide Delivery to Target Tissues Through Antibody Conjugation
Time: 2:00 pm
day: Conference Day One
Details:
- Overview of the current Antibody Oligonucleotide Conjugate (AOC) landscape and discussion into differences in conjugation chemistry between AOCs and ADCs
- Outlining physiological and pharmacokinetic considerations for optimizing oligonucleotide delivery to target tissues through antibody conjugation
- Reviewing data demonstrating enhanced tissue-specific oligonucleotide delivery through AOC approaches compared to traditional delivery methods
